Squamous differentiation in primary urothelial carcinoma of the urinary tract as seen by MAC387 immunohistochemistry

Journal of Clinical Pathology

Volumn 60, Issue 3, 2007, Pages 332-335

  Lopez Beltran, Antonio ^a,d   Requena, Maria J ^b   Alvarez Kindelan, Jose ^b   Quintero, Ana ^b   Blanca, Ana ^b   Montironi, Rodolfo ^c  

^a Universidad de Cordoba   (Spain)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^d Unit of Anatomical Pathology   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY MAC387; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CELL DIFFERENTIATION; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY PELVIS CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL; STAINING;

AGED; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; CELL DIFFERENTIATION; FEMALE; HUMANS; KIDNEY NEOPLASMS; KIDNEY PELVIS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; MIXED TUMOR, MALIGNANT; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 33947416133     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.038802     Document Type: Article

References (13)

1. Martin JE, Jenkins BJ, Zuk RJ, et al. Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder. J Clin Pathol 1989;42:250-3.
2. Mostofi KF, ed. In:Histological typing of urinary bladder tumours. WHO international histological classification of tumours. Geneva: WHO, 1973.
3. Lopez-Behran A, Martin J, Garcia J, et al. Squamous and glandular differentiation in urothelial bladder carcinomas. Histopathology, histochemistry and immunohistochemical expression of carcionoembryonic antigen. Histol Histopathol 1988;3:63-8.
4. Sakamoto N, Tsuneyoshi M, Enjoji M. Urinary bladder carcinoma with a neoplastic squamous component: a mapping study of 31 cases. Histopathology 1992;21:135-41.
5. Lopez-Beltran A, Sauter G, Gasser T, et al. Urothelial tumors: infiltrating urothelial carcinoma. In: Eble JN, Sauter G, Epstein JI, Sesterhenn I, eds. World Health Organization classification of tumors.Pathology and genetics of tumors of the urinary system and male genital organs. Lyon: IARC press, 2004.
6. Honma I, Masumori N, Sato E, et al. Local recurrence after radical cystectomy for invasive bladder cancer: an analysis of predictive factors. Urology 2004;64:744-8.
7. Logothetis CJ, Dexeus FH, Chong C, et al. Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the MD Anderson experience. J Urol 1989;141:33-7.
8. Clark BR, Kelly SE, Fleming S. Calgranulin expression and association with the keratinocyte cytoskeleton. J Pathol 1990;160:25-30.
9. Tungekar MF, Heryet A, Gatter KC. The L1 antigen and squamous metaplasia in the bladder. Histopathology 1991;19:245-50.
10. Harnden P, Southgate J. Cytokeratin 14 as marker of squamous differentition in transitional cell carcinomas. J Clin Pathol 1997;50:1032-3.
11. Sanchez-Carbayo M, Socci ND, Charytonowicz E, et al. Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes. Cancer Res 2002;62:6973- 80.
12. Celis JE, Celis P, Osergaard M, et al. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions. Cancer Res 1999;59:3003-9.
13. Greene FL, Page D, Fleming ID, et al. Morrow M: AJCC cancer staging manual. New York: Springer-Verlag, 2002.